Supplementary immunization activities (SIAs) in South Africa: Comprehensive economic evaluation of an integrated child health delivery platform

Global Health Action

Volumn 6, Issue 1, 2013, Pages

  Verguet, Sté phane ^a   Jassat, Waasila ^b,c   Bertram, Melanie Y ^b   Tollman, Stephen M ^b,d,e   Murray, Christopher J L ^a   Jamison, Dean T ^a   Hofman, Karen J ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c Health Systems Trust   (South Africa)

^d UMEÅ UNIVERSITY   (Sweden)

^e Studies of the Epidemiology of Epilepsy in Demographic Surveillance Systems   (Ghana)

Author keywords

Child health; Cost effectiveness; Integrated delivery platform; Measles; Sub Saharan Africa; Supplementary immunization activity

Indexed keywords

ANTHELMINTIC AGENT; MEASLES VACCINE; POLIOMYELITIS VACCINE; RETINOL; VITAMIN;

ARTICLE; CHILD; CHILD HEALTH; CHILD HEALTH CARE; COST BENEFIT ANALYSIS; COST OF ILLNESS; COST-EFFECTIVENESS; ECONOMICS; HEALTH PROMOTION; HELMINTHIASIS; HUMAN; INTEGRATED DELIVERY PLATFORM; INTEGRATED HEALTH CARE SYSTEM; MEASLES; PREVENTIVE HEALTH SERVICE; SOUTH AFRICA; SUB-SAHARAN AFRICA; SUPPLEMENTARY IMMUNIZATION ACTIVITY;

CHILD HEALTH; COST-EFFECTIVENESS; INTEGRATED DELIVERY PLATFORM; MEASLES; SUB-SAHARAN AFRICA; SUPPLEMENTARY IMMUNIZATION ACTIVITY;

ANTHELMINTICS; CHILD; CHILD HEALTH SERVICES; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE, INTEGRATED; HEALTH PROMOTION; HELMINTHIASIS; HUMANS; IMMUNIZATION PROGRAMS; MEASLES VACCINE; POLIOVIRUS VACCINES; SOUTH AFRICA; VITAMIN A; VITAMINS;

MLCS; MLOWN;

EID: 84880491139     PISSN: None     EISSN: 16549880     Source Type: Journal    
DOI: 10.3402/gha.v6i0.20056     Document Type: Article

References (41)

1. Simons E, Ferrari M, Fricks J, Wannemuehler K, Anand A, Burton A, et al. Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet 2012; 379: 2173-8.
2. World Health Organization. Measles vaccines: WHO position paper. Weekly Epidemiological Record 2009; 84: 349-60.
3. World Health Organization (2012). Retrospective measles data on supplementary immunization activities 2000-2010. Available from: http://www.who.int/immunization_monitoring/data/Summary_Measles_SIAs_2000_to_2011.xls [cited 6 July 2012].
4. de Quadros CA, Izurieta H, Venczel L, Carrasco P. Measles eradication in the Americas: progress to date. J Infect Dis 2004; 189(Suppl. 1): S227-35.
5. Biellik R, Madema S, Taole A, Kutsulukuta A, Allies E, Eggers R, et al. First 5 years of measles elimination in southern Africa. Lancet 2002; 359: 1564-8.
6. Sepúlveda J, Bustreo F, Tapia R, Rivera J, Lozano R, Oláiz G, et al. Improvement of child survival in Mexico: the diagonal approach. Lancet 2006; 368: 2017-27.
7. World Health Organization/UNICEF (2009). Joint annual measles report 2009. Strengthening immunization services through measles control. Geneva: WHO.
8. Grabowsky M, Nobiya T, Ahun M, Donna R, Lengor M, Zimmerman D, et al. Distributing insecticide-treated bednets during measles vaccination: a low-cost means of achieving high and equitable coverage. Bull World Health Organ 2005; 83: 195-201.
9. Grabowsky M, Farrell N, Hawley W, Chimumbwa J, Hoyer S, Wolkon A, et al. Integrating insecticide-treated bednets into a measles vaccination campaign achieves high, rapid and equitable coverage with direct and voucher-based methods. Trop Med Int Health 2005; 10: 1151-60.
10. Doherty T, Chopra M, Tomlinson M, Oliphant N, Nsibande D, Mason J, et al. Moving from vertical to integrated child health programmes: experiences from a multi-country assessment of the Child Health Days approach in Africa. Trop Med Int Health 2010; 15: 296-305.
11. Uzicanin A, Eggers R, Webb E, Harris B, Durrheim D, Ogunbajo G, et al. Impact of the 1996-1997 supplementary measles vaccination campaign in South Africa. Int J Epidemiol 2002; 31: 968-76.
12. World Health Organization (2012). Health topics/poliomyelitis. Polio incidence time series. Available from: http://apps.who.int/immunization_monitoring/en/globalsummary/timeseries/tsincidencedip.htm [cited 8 November 2012].
13. Institute for Health Metrics and Evaluation (2012). IHME database. Seattle, WA: IHME.
14. Labadarios D, editor. The National Food Consumption Survey - Fortification Baseline (NFCS - FB): the knowledge, attitude, behavior and procurement regarding fortified foods, a measure of hunger and the anthropometric and selected micronutrient status of children aged 1-9 years and women of child bearing age: South Africa, 2005. Pretoria: Department of Health, Nutrition Directorate; 2007.
15. Brooker S, Clements ACA, Bundy DAP. Global epidemiology, ecology and control of soil-transmitted helminth infections. Adv Parasitol 2006; 62: 221-61.
16. Mueller DH, Wiseman V, Bakusa D, Morgah K, Daré A, Tchamdja P, et al. Cost-effectiveness analysis of insecticidetreated net distributions as part of the Togo Integrated Child Health Campaign. Malar J 2008; 7: 73.
17. Fiedler JL, Chuko T. The cost of child health days: a case study of Ethiopia's enhanced outreach strategy (EOS). Health Policy Plan 2008; 23: 222-33.
18. Uzicanin A, Zhou F, Eggers R, Webb E, Strebel P. Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa. Vaccine 2004; 22: 3419-26.
19. Acharya A, Diaz-Ortega JL, Tambini G, de Quadros C, Artia I. Cost-effectiveness of measles elimination in Latin America and the Caribbean: a prospective analysis. Vaccine 2002; 20: 3332-41.
20. Dabral M. Cost-effectiveness of supplementary immunization for measles in India. Indian Pediatr 2009; 46: 957-62.
21. Dayan GH, Cairns L, Sangrujee N, Mtonga A, Nguyen V, Strebel P, et al. Cost-effectiveness of three different strategies against measles in Zambian children. Vaccine 2004; 22: 475-84.
22. Levin A, Burgess C, Garrison LP, Bauch C, Babigumira J, Simons E, et al. Global eradication of measles: an epidemiologic and economic evaluation. J Infect Dis 2011; 204(Suppl. 1): S98-106.
23. Bishai D, Johns B, Nair D, Nabyonga-Orem J, Fiona-Makmot B, Simons E, et al. The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda. J Infect Dis 2011; 204(Suppl. 1): S107-15.
24. Murray CJL, Rajaratnam JK, Marcus J, Laakso T, Lopez AD. What can we conclude from death registration? Improved methods for evaluating completeness. PloS Medicine 2010; 7(4): e1000262.
25. Birnbaum JK, Murray CJL, Lozano R. Exposing misclassified HIV/AIDS deaths in South Africa. Bull World Health Organ 2011; 89(4): 278-85.
26. Imdad A, Herzer K, Mayo-Wilson E, Yakoob MY, Bhutta ZA. Vitamin A supplementation for preventing morbidity and mortality in children from 6 months to 5 years of age. Cochrane Database Syst Rev 2010. Art. No. CD008524.
27. Wolfson LJ, Grais RF, Luquero FJ, Birmingham ME, Strebel PM. Estimates of measles case fatality ratios: a comprehensive review of community-based studies. Int J Epidemiol 2009; 28: 192-205.
28. Caulfield LE, Richard SA, Rivera JA, Musgrove P, Black RE. Stunting, wasting, and micronutrient deficiency disorders. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al., eds. Disease control priorities in developing countries. 2nd ed. Washington, DC: The World Bank; 2006, pp. 351-67.
29. Babigumira JB, Levin A, Burgess C, Garrison LP, Bauch CT, Braka F, et al. Assessing the cost-effectiveness of measles elimination in Uganda: local impact of a global eradication program. J Infect Dis 2011; 204(Suppl. 1): S116-23.
30. Laxminarayan R, Mills AJ, Breman JG, Measham AR, Alleyne G, Cleason M, et al. Advancement of global health: key messages from the Disease Control Priorities Project. Lancet 2006; 367: 1193-208.
31. Aaby P, Bhuiya A, Nahar L, Knudsen K, de Francisco A, Strong M. The survival benefit of measles immunization may not be explained entirely by the prevention of measles disease: a community study from rural Bangladesh. Int J Epidemiol 2003; 32: 106-15.
32. Fine PEM. Commentary: non-specific effects of measles vaccine - more grist for the mill. Int J Epidemiol 2003; 32: 116-7.
33. Hotez PJ, Bundy DAP, Beegle K, Brooker S, Drake L, de Silva N, et al. Helminth infections: soil-transmitted helminth infections and schistosomiasis. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al., eds. Disease control priorities in developing countries. 2nd ed. Washington, DC: The World Bank; 2006, pp. 467-82.
34. Musgrove P, Fox-Rushby J. Cost-effectiveness analysis for priority setting, Chapter 15. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al., eds. Disease control priorities in developing countries. 2nd ed. Washington, DC: The World Bank; 2006, pp. 271-85.
35. Kahn MM, Ehreth J. Costs and benefits of polio eradication: a long-run global perspective. Vaccine 2003; 21: 702-5.
36. Verguet S, Jassat W, Hedberg C, Tollman S, Jamison DT, Hofman KJ. Measles control in sub-Saharan Africa: South Africa as a case study. Vaccine 2012; 30: 1594-600.
37. Bhutta ZA, Chopra M, Axelson H, Berman P, Boerma T, Bryce J, et al. Countdown to 2015 decade report (2000-10): taking stock of maternal, newborn, and child survival. Lancet 2010; 375: 2032-44.
38. Christie A, Gay A. Response to Heymann DL, Fine PE, Girffiths UK, Hall AJ, Mounier-Jack S. Measles eradication: past is prologue. Lancet 2010; 376: 1719-20. Lancet 2011; 377: 808.
39. Christie A, Gay A. Response to Heymann DL, Fine PE, Girffiths UK, Hall AJ, Mounier-Jack S. Measles eradication: past is prologue. Lancet 2011; 377: 808.
40. Goodson JL, Kulkarni MA, Vanden Eng JL, Wannemuehler KA, Cotte AH, Desrochers RE, et al. Improved equity in measles vaccination from integrating insecticide-treated bednets in a vaccination campaign, Madagascar. Trop Med Int Health 2012; 17: 430-7.
41. World Health Organization (2012). The reaching every district strategy. Available from: http://www.who.int/immunization_delivery/systems_policy/RED-FactSheet.pdf [cited 14 August 2012].